Experimental study demonstrates pH-sensitive and magnetically guided doxorubicin delivery in cancer models, suggesting potential for novel targeted oncological therapies.
The reported supramolecular arrangement offers an attractive strategy for the pH-sensitive and magnetically-guided release of doxorubicin, which could allow exploring novel therapeutic schemes against cancer.
No takes yet. Share an insight, caveat, or question.
Espinola-Portilla et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: